With Novo Nordisk's patent gone in India, a dozen generics have flooded in at a fraction of the price, and a market of 10 crore diabetics is waiting
01-Jun-2026•Value Research Team
Welcome to the New Value Research!
2 min read•By Value Research
NPS Swasthya: buy the cover, not the corpus
6 min read•By Aakar Rastogi
The next scam will not look like a scam
14 min read•By Ruchira Sharma